Research study Program year 2024 Source: CMS Open Payments

A 24-Week, Phase 3, Multicentre, Randomised, Double-Blind, Efficacy An

Research payments

$6,009,491

1,372 payments

Through program year 2024, $6,009,491 in research payments was reported against A 24-Week, Phase 3, Multicentre, Randomised, Double-Blind, Efficacy An, across 1,372 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$98	1
2023	Research	$4,349	8
2022	Research	$513,854	251
2021	Research	$2,486,375	534
2020	Research	$2,809,074	551
2019	Research	$195,741	27

Breakdown

Who paid Research payments · program years 2019–2024

GlaxoSmithKline, LLC. $6,009,491 1,372 payments

Who received the money Research payments · program years 2019–2024

Arizona Arthritis And Rheumatology Associates Pc Organisation paid for research $709,988 204 payments
Future Care Solution LLC Organisation paid for research $691,644 22 payments
Dynamed Clinical Research LP Organisation paid for research $538,659 111 payments
Biovin Enterprises LLC Organisation paid for research $535,943 63 payments
Tamar Brionez MD PA Organisation paid for research $272,164 47 payments
Premier Clinical Research Organisation paid for research $239,190 41 payments
Precision Comprehensive Clinical Research Solutions Organisation paid for research $227,194 29 payments
Inland Rheumatolgy Clinical Trials INC Organisation paid for research $185,614 32 payments
Physicians Research Collaboration Organisation paid for research $175,144 55 payments
Accurate Clinical Management LLC Organisation paid for research $159,941 53 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.